EPRX
Price
$5.74
Change
-$0.02 (-0.35%)
Updated
Sep 26 closing price
Capitalization
290.89M
39 days until earnings call
IRON
Price
$65.55
Change
+$3.05 (+4.88%)
Updated
Sep 26 closing price
Capitalization
2.28B
40 days until earnings call
Interact to see
Advertisement

EPRX vs IRON

Header iconEPRX vs IRON Comparison
Open Charts EPRX vs IRONBanner chart's image
Eupraxia Pharmaceuticals
Price$5.74
Change-$0.02 (-0.35%)
Volume$58.49K
Capitalization290.89M
Disc Medicine
Price$65.55
Change+$3.05 (+4.88%)
Volume$352.25K
Capitalization2.28B
EPRX vs IRON Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. IRON commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a StrongBuy and IRON is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (EPRX: $5.74 vs. IRON: $65.55)
Brand notoriety: EPRX and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 106% vs. IRON: 106%
Market capitalization -- EPRX: $290.89M vs. IRON: $2.28B
EPRX [@Biotechnology] is valued at $290.89M. IRON’s [@Biotechnology] market capitalization is $2.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 7 TA indicator(s) are bullish while IRON’s TA Score has 4 bullish TA indicator(s).

  • EPRX’s TA Score: 7 bullish, 3 bearish.
  • IRON’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than IRON.

Price Growth

EPRX (@Biotechnology) experienced а -3.69% price change this week, while IRON (@Biotechnology) price change was +7.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.28B) has a higher market cap than EPRX($291M). EPRX YTD gains are higher at: 81.073 vs. IRON (3.391). EPRX has higher annual earnings (EBITDA): -28.83M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. EPRX (19.8M). EPRX has less debt than IRON: EPRX (35.1K) vs IRON (30.9M). EPRX (0) and IRON (0) have equivalent revenues.
EPRXIRONEPRX / IRON
Capitalization291M2.28B13%
EBITDA-28.83M-142.42M20%
Gain YTD81.0733.3912,391%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.8M650M3%
Total Debt35.1K30.9M0%
TECHNICAL ANALYSIS
Technical Analysis
EPRXIRON
RSI
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 30 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVTIX11.480.11
+0.97%
Transamerica Mid Cap Value Opps I
ATGAX41.240.35
+0.86%
Cantor Fitzgerald Equity Opp A
GXXIX14.010.10
+0.72%
abrdn US Sustainable Leaders InstlSvc
GAOFX22.210.09
+0.41%
JPMorgan Global Allocation R4
JHEQX34.580.04
+0.11%
JPMorgan Hedged Equity I

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-0.35%
NAGE - EPRX
34%
Loosely correlated
+3.72%
ETNB - EPRX
29%
Poorly correlated
N/A
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
-0.75%
IRON - EPRX
26%
Poorly correlated
+4.88%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+4.88%
NUVL - IRON
54%
Loosely correlated
+4.99%
SYRE - IRON
52%
Loosely correlated
+4.04%
CGON - IRON
51%
Loosely correlated
+2.91%
XNCR - IRON
50%
Loosely correlated
+12.00%
CRNX - IRON
50%
Loosely correlated
+27.92%
More